SCM
ACLX

Soleus Capital Management’s Arcellx ACLX Stock Holding History

Soleus Capital Management’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,000
Closed -$1.96M – 95
2025
Q4 		$1.96M Sell
30,000
-70,000
-70% -$5.58M 0.07% 81
2025
Q3 		$8.21M Sell
100,000
-23,031
-19% -$1.66M 0.41% 51
2025
Q2 		$8.1M Sell
123,031
-30,000
-20% -$1.87M 0.54% 44
2025
Q1 		$10M Buy
153,031
+32,000
+26% +$2.17M 0.72% 36
2024
Q4 		$9.28M Buy
121,031
+28,000
+30% +$2.42M 0.58% 41
2024
Q3 		$7.77M Sell
93,031
-77,710
-46% -$5.17M 0.6% 44
2024
Q2 		$9.42M Buy
170,741
+20,741
+14% +$1.13M 0.83% 39
2024
Q1 		$10.4M Sell
150,000
-9,000
-6% -$571K 0.77% 38
2023
Q4 		$8.82M Sell
159,000
-484,777
-75% -$21.9M 0.98% 32
2023
Q3 		$23.1M Sell
643,777
-358,222
-36% -$12.3M 2.13% 14
2023
Q2 		$31.7M Sell
1,001,999
-246,148
-20% -$9.41M 3.52% 8
2023
Q1 		$38.5M Buy
1,248,147
+145,700
+13% +$4.42M 3.98% 4
2022
Q4 		$34.2M Sell
1,102,447
-137,466
-11% -$3.15M 4.9% 5
2022
Q3 		$23.3M Buy
1,239,913
+330,174
+36% +$6.32M 3.16% 11
2022
Q2 		$16.4M Sell
909,739
-80,000
-8% -$1.03M 2.57% 10
2022
Q1 		$13.9M Buy
+989,739
New +$16.5M 1.79% 21

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Soleus Capital Management's ACLX Position: Q1 2026 in Review

Soleus Capital Management sold out of Arcellx (ACLX) in Q1 2026, closing a stake of 30,000 shares — an estimated $1.96M sold.

Soleus Capital Management first reported a position in ACLX in Q1 2022 and held it in 16 quarters. The position peaked at $38.5M in Q1 2023. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Soleus Capital Management reported no remaining Arcellx position as of Q1 2026 after selling out during the quarter.
  • Soleus Capital Management sold 30,000 Arcellx shares in Q1 2026, an estimated $1.96M.
  • Soleus Capital Management first reported a position in Arcellx in Q1 2022 and held it in 16 quarters.
  • Soleus Capital Management's Arcellx position peaked at $38.5M in Q1 2023.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.